These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?]. Blagova OV; Nedostup AV Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214 [TBL] [Abstract][Full Text] [Related]
7. Comparative influence of propranolol and verapamil on glycemic control and histamine sensitivity associated with L-thyroxine-induced hyperthyroidism - an experimental study. Bhatt PA; Makwana D Fundam Clin Pharmacol; 2008 Feb; 22(1):53-9. PubMed ID: 18251722 [TBL] [Abstract][Full Text] [Related]
8. Calcium channel blocking drugs in the management of drug dependence, withdrawal and craving. A clinical pilot study with nifedipine and verapamil. Shulman A; Jagoda J; Laycock G; Kelly H Aust Fam Physician; 1998 Jan; 27 Suppl 1():S19-24. PubMed ID: 9503731 [TBL] [Abstract][Full Text] [Related]
9. Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs. Mills TA; Kawji MM; Cataldo VD; Pappas ND; O'Meallie LP; Breaux DM; Glancy DL J La State Med Soc; 2004; 156(6):327-31. PubMed ID: 15688675 [TBL] [Abstract][Full Text] [Related]
10. Altered cardiovascular responses to nitrosorbide in alcohol withdrawal. Kähkönen S; Zvartau EE Neuropsychobiology; 2003; 48(3):124-30. PubMed ID: 14586161 [TBL] [Abstract][Full Text] [Related]
11. Heart rate variability and sympathetic skin response in male patients suffering from acute alcohol withdrawal syndrome. Bär KJ; Boettger MK; Neubauer R; Grotelüschen M; Jochum T; Baier V; Sauer H; Voss A Alcohol Clin Exp Res; 2006 Sep; 30(9):1592-8. PubMed ID: 16930222 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide mediates cardiovascular symptoms in alcohol withdrawal. Kähkönen S; Boris B; Edwin Z Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):761-5. PubMed ID: 17291656 [TBL] [Abstract][Full Text] [Related]
13. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ; Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652 [TBL] [Abstract][Full Text] [Related]
14. Tissue perfusion in relation to cardiac output during continuous positive-pressure ventilation and administration of propranolol or verapamil. Elowsson P; Norlén K; Jakobson S Acta Anaesthesiol Scand; 1998 Aug; 42(7):816-24. PubMed ID: 9698959 [TBL] [Abstract][Full Text] [Related]
15. Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly. Groszmann RJ Gastroenterology; 1997 Nov; 113(5):1794-7. PubMed ID: 9352888 [No Abstract] [Full Text] [Related]
16. [Tolerance to nitrates in patients with angina and effect of plasmapheresis]. Koziolova NA Ter Arkh; 2001; 73(12):21-5. PubMed ID: 11858102 [TBL] [Abstract][Full Text] [Related]
17. Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy. Rogers R; Prpic R Med J Aust; 1998 Oct; 169(8):425-7. PubMed ID: 9830391 [TBL] [Abstract][Full Text] [Related]
18. [Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences]. Krämer B; Kübler W Dtsch Med Wochenschr; 1984 Mar; 109(12):465-71. PubMed ID: 6142815 [No Abstract] [Full Text] [Related]
19. [Drugs in secondary prevention of ischemic heart disease: achievements, problems and prospects]. Metelitsa VI Kardiologiia; 1989 Nov; 29(11):57-62. PubMed ID: 2575683 [TBL] [Abstract][Full Text] [Related]